b-Catenin-mediated Wnt signaling is essential in embryonic development and in adult tissues. Recent studies have demonstrated that Axin not only plays an important inhibitory role in coordinating b-catenin degradation, but is itself degraded by the low-density-lipoprotein receptorrelated protein (LRP)5/6 Wnt co-receptor. Here, we demonstrate that the endocytic adaptor molecule Disabled-2 (Dab2), which we have previously demonstrated to act as an inhibitor of b-catenin signaling, interacts with Axin and prevents its interaction with and degradation by the LRP5 co-receptor, thereby increasing its half-life and stabilization. Dab2 levels induced during retinoic acidinduced differentiation of F9, or during transforming growth factor-b-induced epithelial-mesenchymal transdifferentiation of mouse mammary epithelial cells result in the stabilization of Axin and concomitant inhibition of b-catenin signaling. Ectopic expression of Dab2 in F9 cells as well as in transformed cell lines results in increased Axin expression and attenuation of Wnt-mediated signaling. We conclude that Dab2 may play an important role in the maintenance of the differentiated state and restrain Wnt-mediated proliferation through its association with and modulation of Axin.
Introduction
Canonical Wnt signaling is mediated through the regulated phosphorylation and degradation of the transcriptional coactivator b-catenin (Tolwinski and Wieschaus, 2004) . In the absence of Wnt, b-catenin is assembled in a multimeric b-catenin destruction complex that contains, amongst others, Axin, adenomatous polyposis coli (APC) tumor suppressor protein, casein kinase 1 and glycogen synthase kinase 3 (GSK3). In this complex, b-catenin is sequentially phosphorylated at a cluster of Ser and Thr residues near its N terminus by casein kinase 1 and GSK3, and earmarked for degradation through the SCF bTrCP -mediated ubiquitin-proteasome pathway. In the presence of Wnt, activation of the frizzled and low-density-lipoprotein receptor-related protein (LRP)5/6/arrow co-receptors results in destabilization of the b-catenin destruction complex and inhibition of b-catenin phosphorylation and degradation. Stabilized b-catenin then enters the nucleus and interacts with transcriptional regulators, including leukocyte enhance factor-1 and T cell factor, and leads to Wnt responsive gene expression (He et al., 2004; Cadigan and Liu, 2005) .
The mechanism by which Wnt promotes destabilization of the b-catenin destruction complex remains unclear, although this process is likely to involve the Dishevelled proteins (Dvl). Dvls are scaffolding proteins that act upstream in the Wnt pathway and are recruited to the plasma membrane by frizzled (Cliffe et al., 2003; Wong et al., 2003) . Early studies focused on the role of Dvl in mediating the effects on GSK3 kinase (Liu et al., 2002) . Recently, however, GSK3-independent regulation of Wnt signaling has been suggested (Tolwinski and Wieschaus, 2004) involving Dvl and the scaffolding protein Axin that binds APC, b-catenin, GSK3, casein kinase 1 and Dvl (Polakis, 2002) . Axin facilitates the formation of the b-catenin destruction complex, resulting in b-catenin phosphorylation and degradation. Axin levels are very low, approximately 1000 times lower than those of the other destruction complex components, and thus Axin might be the limiting component in the pathway . Axin levels are regulated in a Wnt-dependent manner. Wnt stimulation leads to dephosphorylation and destabilization of Axin, and this decrease in Axin prevents the formation of the destruction complex and to a stabilization of b-catenin (Willert et al., 1999; Yamamoto et al., 1999; Jho et al., 2002) . Axin turnover, therefore, modulates the level of b-catenin transcriptional activity and the output of Wnt signaling.
The intracellular domain of the LRP5/6 and Arrow co-receptors can bind and recruit Axin to the plasma membrane, providing a direct link between the Wnt coreceptor and a Wnt intracellular signaling mediator (reviewed in He et al., 2004) . Wnt stimulation induces the sequential phosphorylation of LRP5/6 co-receptor by a 'dual kinase' mechanism involving GSK3 and casein kinase 1 at multiple PPPSP sites, reiterated five times in the cytoplasmic domain of LRP5/6 Zeng et al., 2005) . This phosphorylation of LRP5/6 promotes the recruitment and engagement of LRP5/6 with Axin (Zeng et al., 2005) . Dvl aids in the Wnt-induced recruitment of Axin to the membrane and to its interaction with the phosphorylated LRP5/6 co-receptor, and this interaction leads to Axin dephosphorylation and degradation (Cliffe et al., 2003) . As the levels of Axin are decreased, the destruction complex is destabilized and b-catenin levels accumulate.
Disabled-2 (Dab2) is a widely expressed adaptor protein shown to be involved in several receptor-mediated signaling pathways (Xu et al., 1995; Hocevar et al., 2001; Prunier et al., 2004) . Like other adaptors, Dab2 has no catalytic activity but elicits its function through interaction and modulation of other proteins. Dab2 contains a conserved N-terminal phosphotyrosine-binding domain (Yun et al., 2003) that binds to members of the low-density lipoprotein receptor (LDLR) family and with phosphoinositides (Morris and Cooper, 2001) . Its linker and C-terminal regions bind clathrin, the clathrin adaptor protein AP2 and myosin VI, facilitating clathrincoated pit assembly and receptor-mediated endocytosis (Morris and Cooper, 2001; Mishra et al., 2002; Morris et al., 2002) . The endocytic and vesicular trafficking functions of Dab2 are postulated to mediate its effects on cellular signaling (Morris et al., 2002) .
Previously we reported that Dab2 functions as a negative regulator of canonical Wnt signaling by stabilizing the b-catenin destruction complex, and postulated that this may contribute to its proposed role as a tumor suppressor (Hocevar et al., 2003) . Dab2 overexpression inhibits Wnt-3A-induced accumulation of b-catenin, and Dab2 ablation leads to increased nuclear b-catenin and elevated b-catenin/T cell factor/ leukocyte enhance factor-1-dependent gene induction. Dab2 associates with Dvl-3 and its overexpression was shown to decrease Dvl3/Axin interactions and maintain Axin/b-catenin/GSK3 interactions (Hocevar et al., 2003) . In this report, we demonstrate that undifferentiated and low-Dab2-expressing cells are Wnt-signaling competent, whereas differentiated and high-Dab2-expressing cells are Wnt-signaling incompetent. Induced endogenous Dab2 associates with Axin and prevents Axin association, and subsequent degradation, with the LRP5 co-receptor, resulting in a stabilization and an increase in the half-life of Axin. We further demonstrate that in low-Dab2-expressing transformed cell lines that ectopically expressed Dab2 results in increased Axin expression levels and modulation of b-catenin signaling only in cells with wild-type (WT) APC.
Results

RA-induced Dab2 inhibits Wnt signaling
The mouse F9 cell line is a model for RA-induced visceral endoderm differentiation. Since Dab2 expression in these cells is induced during differentiation (Smith et al., 2001; Prunier and Howe, 2005 ) and Dab2 is a negative regulator of Wnt signaling (Hocevar et al., 2003) , we used this model to examine the role of Dab2 in Wnt-mediated signaling. Figure 1a demonstrates that RA (100 nM) significantly increases Dab2, with a concomitant increase in the expression of the visceral endoderm marker GATA binding protein 4 (GATA-4) (Smith et al., 2001) . We next investigated whether F9 cells displayed differentiation state-dependent responsiveness to Wnt and whether Dab2 played any regulatory role in the transitional response of these cells to Wnt. We took advantage of an F9 cell line, which we have established in which Dab2 expression is ablated by stable expression of small interfering RNA (si-RNA) (siDab2/F9 cells) (Prunier and Howe, 2005) . As shown in Figures 1b and c , Wnt stimulation for either short term (0-3 h) or long term (0-72 h) has no effect either on Dab2 or on the differentiation marker Sparc (Wiles, 1988) . RA-induced Dab2 and Sparc levels were unaffected by Wnt treatment and in siDab2/F9 cells, Dab2 and Sparc are not induced and Wnt treatment has no effect. The differentiation marker GATA-4 is not induced in Dab2-ablated cells (Prunier and Howe, 2005) and by cDNA array analysis villin and collagen type IV are also not induced (data not shown).
We next investigated the Wnt signaling status of these cells by analysis of nuclear b-catenin (Figure 2a 
RA-induced Dab2 stabilizes Axin
Since Axin has been implicated as a primary regulator of canonical Wnt signaling , we wanted to determine whether the inhibitory effect of Dab2 was mediated through effects on Axin. Figure 3a demonstrates that Wnt-induced transactivation of TOPFLASH (Shibamoto et al., 2004) . Further, increased Axin levels are associated with a decrease in b-catenin, confirming its inhibitory role on b-catenin signaling. In Dab2-ablated cells (siDab2/F9; Figure 3b , right panels), RA treatment failed to induce Dab2, Axin and Dickkopf-1 expression levels, or attenuate b-catenin levels. In Figure 3c , we confirm that Wnt treatment of undifferentiated (ÀRA) cells leads to a time-dependent decrease in Axin expression, whereas in RA-differentiated ( þ RA) cells, basal Axin is elevated compared with undifferentiated levels, and Wnt stimulation does not decrease Axin expression. The experiment was repeated three times and the quantitation of the results are depicted in Figure 3d . These results suggest that Axin levels are stabilized during RA-induced differentiation of F9 cells, concomitant with increased expression of Dab2, and that once the cells are differentiated, Axin is not regulated in a Wnt-dependent manner.
To directly determine Dab2's role in regulating Axin expression, we overexpressed Flag-tagged Dab2 and examined endogenous and ectopically overexpressed Axin levels. Figure 4a demonstrates that ectopically expressed Dab2 results in an increase in endogenous Axin. Figure 4b demonstrates that Dab2, in a concentration-dependent manner, leads to an increase expression of exogenous Myc-tagged Axin. In Figure 4c 
Dab2 inhibits Axin/LRP5 interactions
Axin has been shown to be destabilized by Wnt following its translocation and interaction with the LRP5/6 Wnt co-receptors. To investigate the effects of Dab2 on LRP5/6/Axin interactions, cells were transfected with Flag-tagged LRP5 and Myc-Axin in the presence of increasing concentrations of Flag-tagged Dab2 expression plasmid, and anti-Myc-Axin immunoprecipitates (IPs) were analysed for co-immunoprecipitating proteins. Figure 5a (a-Flag panel) demonstrates that in the absence of Dab2, LRP5 is co-precipitated in an Axin IP, indicating an interaction between LRP5/ Axin. Increasing Dab2 expression, however, significantly reduces the level of co-immunoprecipitated LRP5 in the Axin IP. The results also demonstrate an interaction between Dab2/Axin, in that there is a Steady-state levels of LRP5/6 do not change upon Dab2 overexpression or during the course of Wnt treatment (blot: a-LRP5/6). The data of Figure 5 establish interactions between LRP5/Axin and Dab2/Axin, but, more importantly, indicate that Dab2 expression levels modulate the interaction between LRP5/Axin and the Axin-dependent phosphorylation of LRP5/6. Thus, the ability of Dab2 to stabilize and increase the half-life of Axin may be due to its ability to inhibit LRP5/Axin interactions at the plasma membrane. We next examined whether the effects of Dab2 on Axin expression and on b-catenin signaling were specific to F9 cells. We previously demonstrated in a TGFbinduced epithelial to mesenchymal transdifferentiation model in mouse mammary epithelial cells (NMuMG) that Dab2 expression is induced and required for transdifferentiation (Prunier and Howe, 2005) . As previously demonstrated, TGFb induces Dab2 expression levels in these cells following a 24-h treatment (Figure 6a, a-Dab2 panel) . (Figure 6b ). This is further confirmed by the results in Figure 6d , where Dab2 is shown to attenuate Wntmediated TOPFLASH transactivation in PC3 and HCT116 cells, but not in SW480 and SW620 cells (data not shown). While the SW480 and SW620 cell lines showed Dab2 modulation of Axin, b-catenin in these cells was not decreased (Figure 6b ), nor was Dab2 and Axin overexpression able to modulate Wnt-mediated TOPFLASH transactivation (data not shown). PC3 and HCT116 cells express WT APC, whereas both the SW480 and SW620 cells express truncated, mutant forms of APC (Daniel and Reynolds, 1995; Ilyas et al., 1997) . To determine whether WT APC could rescue the effects of Dab2 on TOPFLASH transactivation in SW480 and SW620 cells, we cotransfected cells with TOPFLASH and an inducible WT APC expression plasmid (Morin et al., 1996) , in the presence or absence of Dab2 (1 and 2 mg). The APC status of the cells is demonstrated in Figure 6e . PC3 and HCT116 express full-length WT APC, whereas SW480 and SW620 express mutant APC. Induction with 50 mM ZnCl 2 for 24 h resulted in the expression of WT APC in SW480 and SW620 cells (Figure 6e ). SW480 and SW620 cells have elevated basal TOPFLASH activity, and Wnt treatment does not result in enhanced transactivation (Figure 6f ). Induction and expression of WT APC in both SW480 and SW620 cells results in Wnt-induced TOPFLASH transactivation, which is attenuated by cotransfection with increasing concentrations of Dab2 (Figure 6f ). These results demonstrate that Dab2 
Discussion
Mouse embryonal F9 cells are an in vitro model for visceral endoderm differentiation (Smith et al., 2001; Prunier and Howe, 2005) , and have been demonstrated to resemble absorptive epithelial cells (Shibamoto et al., 2004) . and (e) HCT116 cells were transfected with the TOPFLASH luciferase reporter in the presence of 1 and 2 mg of Flag-tagged Dab2, and luciferase activity was determined as described above. (e) PC3, HCT116, SW480 and SW620 cell lysates together with lysates from SW480 and SW620 transfected with WT APC were prepared and analysed by western blot using a-APC antibody. Following transfection, WT APC was induced with 50 mM ZnCl 2 for 24 h as described (Morin et al., 1996) . (f) SW480 and SW620 cells transfected with WT APC were transfected with the TOPFLASH luciferase reporter in the presence of 1 and 2 mg of Flag-tagged Dab2, and luciferase activity was determined as described above. APC, adenomatous polyposis coli; Dab2, Disabled-2; TGFb, transforming growth factor-b; WT, wild type.
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we demonstrate that in the absence of Dab2 the cells are responsive to b-catenin signaling and upon differentiation and induction of Dab2, cells become refractory to Wnt signaling. Thus, in differentiated cells, we speculate that Dab2 maintains the differentiated state and restrains proliferation through its negative regulation of Wnt signaling, whereas in the proliferative state, Wnt attenuates expression of its inhibitor to maintain proliferation and block induction of the differentiation state. These results are consistent with a recent report (Lickert et al., 2005) demonstrating that Dab2 gene expression is upregulated in conditional b-catenin mutant mouse embryos, suggesting that not only is Dab2 a Wnt/b-catenin target gene, but that b-catenin signaling leads to its attenuation. In many intestinal neoplasias, constitutive Wnt signaling (Gregorieff and Clevers, 2005) and aberrantly low levels of Dab2 protein (Kleeff et al., 2002; Prunier et al., 2004) are often observed. In fact, Dab2 has been designated as a putative tumor suppressor gene because its expression is often found to be downregulated in many transformed cell lines. In these tumors, therefore, constitutive expression of Wnt target genes such as cyclin D1 and c-myc may not only lead to excessive proliferation, but may also block the induction of differentiation markers and Wnt inhibitors such as Dab2. We show in transformed epithelial cell lines that Dab2 and Axin levels are low and that the cells have elevated b-catenin and cyclin D1 levels. Transient ectopic expression of Dab2 in these lines is able to restore Axin expression, and, in the two lines that have previously been demonstrated to express WT APC (Daniel and Reynolds, 1995; Ilyas et al., 1997) Recent studies demonstrate that Axin levels play a key regulatory function in b-catenin/Wnt signaling (Cliffe et al., 2003; Lee et al., 2003) . We demonstrate that Dab2 not only interacts with Axin, but also stabilizes its expression. Dab2 expression, whether endogenously induced during differentiation or ectopically overexpressed, results in the stabilization of Axin. Since Wnt stimulation promotes Axin/LRP5/6 interactions , leading to Axin destabilization, and the phosphotyrosine-binding domain of Dab2 is known to bind to other LDL receptor family members (Morris and Cooper, 2001) , we reasoned that Dab2 may interact with LRP5/6 and thereby block LRP5/6/Axin interactions. While we could not demonstrate an interaction between Dab2 and LRP5 (data not shown), we did observe that Dab2 blocked the interaction of LRP5/Axin and the phosphorylation of LRP5/6 in response to Wnt. We postulate that the ability of Dab2 to stabilize and increase the half-life of Axin may be due to its ability to interfere with LRP5/Axin interactions at the plasma membrane.
How Dab2 interferes with Axin/LRP5/6 at the plasma membrane is unknown. Axin and Dvl are colocalized in punctate intracellular 'dots' thought to represent intracellular vesicles (Fagotto et al., 1999; Cliffe et al., 2003) . Wnt also induces co-clustering of LRP5/6 and Dvl into plasma membrane-associated aggregates that contain Wnt-pathway components (Bilic et al., 2007) . Both Axin and Dvl contain phospholipid-binding motifs that are conserved in their DIX domains, and this domain in the Dvl protein is essential for its recruitment to membranes and its function in controlling the degradation of b-catenin (Capelluto et al., 2002) . On the basis of these findings, a 'vesicle transport' model has been proposed whereby Axin and Dvl are associated with the same vesicle, and Dvl recruits or shuttles Axin to the plasma membrane, where it interacts with, and is subsequently regulated by, the LRP5/6 co-receptors (Cliffe et al., 2003; He et al., 2004) . Thus, endocytic vesicles are postulated to provide a platform for assembly and transport of the Axin complex to the plasma membrane for inactivation by Wnt receptors (Cliffe et al., 2003) . Consistent with this model, several recent reports have demonstrated that endocytosis and endosomal transport have been shown to facilitate and maximize Wnt signaling in Drosophila (Chen et al., 2003; Yamamoto et al., 2006) .
Dab2 is an adaptor involved in endocytosis and protein trafficking (Morris and Cooper, 2001; Mishra et al., 2002) . It contains a phosphotyrosine-binding domain that binds to both LDLR family members and directly to phospholipids. In addition, Dab2 binds to clathrin and the clathrin adaptor AP-2 and displays a punctate 'dot-like' staining pattern in cells, suggestive of its association with intracellular vesicles, endocytic and secretory vesicles (Morris and Cooper, 2001; Kakimura and Cooper, 2006) . Overexpressed Dab2 results in a major redistribution of the AP-2 clathrin adaptor into large clusters or aggregates near the cell periphery that are devoid of clathrin (Morris and Cooper, 2001) . It is postulated that high Dab2 levels saturate AP-2-binding sites, sequestering and preventing AP-2 recycling to the cell surface. In the absence of AP-2 at the membrane, receptor complexes are not stabilized and clathrincoated pits are not formed. On the basis of these data, we postulate that in cells with low Dab2, such as undifferentiated F9, Wnt signaling is operative because endocytosis and endosomal transport of the Wnt signalosome are maintained and allowed to recycle to the plasma membrane. In cells that have induced and high levels of Dab2, such as RA-differentiated F9 cells, the Wnt signalosome is either not properly endocytosed and/or not properly assembled at the plasma membrane due to AP-2 sequestration. Interestingly, AP-2 and Dvl associations have recently be shown to be required for frizzled endocytosis (Yu et al., 2007) . We have previously demonstrated that Dab2 can interact with Dvl and that Dab2 overexpression can disrupt Axin/ Dvl interactions (Hocevar et al., 2003 ). Herein we demonstrate that Dab2 stabilizes Axin expression by preventing its interaction with the LRP5 co-receptor. Since Dvl proteins are required for the recruitment of Axin to LRP5 (Cliffe et al., 2003; Zeng et al., 2005) and LRP5 phosphorylation (Bilic et al., 2007) , we postulate that disruption of Dvl/Axin interactions by Dab2 results in Axin not being recruited to the membrane, resulting in its stabilization and attenuation of Wnt signaling.
Materials and methods
Cell culture, transient transfection and luciferase assay F9 mouse embryonic carcinoma cells and the siDab2F9 clone were cultured and differentiated with RA (100 nM) as described (Prunier and Howe, 2005) . NMuMG cells were cultured and differentiated with TGFb as described (Prunier and Howe, 2005) . PC3, HCT116, SW480 and SW620 were obtained from American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics (penicillin and streptomycin). For luciferase reporter and transient expression assays, cells were transiently transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) as previously described (Hocevar et al., 2003) . Relative luciferase activity is expressed as the ratio of TOP/FOPFLASH and cyclin D1 activity in control and Wnt-3A-treated cells. All assays were performed in triplicate and the data are presented as means ± s.d. Wnt-3A-conditioned media was prepared as described previously from mouse L-cells overexpressing Wnt-3A (Shibamoto et al., 1998) .
DNA constructs and antibodies TOPFLASH and FOPFLASH luciferase reporter constructs were purchased from Upstate (Lake Placid, NY, USA). The cyclin D1 promoter luciferase construct has been described previously (Herber et al., 1994) . Expression constructs for Myc-Axin (Furuhashi et al., 2001) , Flag-tagged Dab2 (Hocevar et al., 2001) and Flag-tagged LRP5 (kindly provided by Dr Dianqing Wu, University of Connecticut) have been previously described. The monoclonal antibody to Dab2/p96 was purchased from Transduction Laboratories (San Jose, CA, USA). Anti-Axin antibody was purchased from Upstate, anti-Myc antibody from Cell Signaling Technology (Danvers, MA, USA), anti-Flag antibody from Sigma (St Louis, MO, USA), anti-cyclin D1 and anti GATA-4 antibodies from Santa Cruz Biotechnologies (Santa Cruz, CA, USA), anti-LRP5 antibody from ZyMed (South San Francisco, CA, USA), and anti-Sparc antibody from R&D Systems (Minneapolis, MN, USA). Anti-APC antibody was purchased from Oncogene (San Diego, CA, USA), anti-Dickkopf-1 was from Novus (Littleton, CO, USA) and anti-phospho-LRP5/6 was kindly provided by Dr Zeng and Dr He.
Preparation of cell lysates, immunoprecipitation and western blot analysis For immunoprecipitation and western blot analysis, cells were lysed in buffer D and immunoprecipitation carried out as previously described (Hocevar et al., 2003) . For APC western blot assay, APC expression was induced with ZnCl 2 (50 mM) for 24 h as described (Morin et al., 1996) , and lysates were run on 4.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred to polyvinylidene difluoride membrane overnight at 300 mA. Preparation of cytosolic and nuclear fractions was carried out as described (Hocevar et al., 2003) .
Reverse transcription-PCR analysis RNA was isolated using the RNeasy Mini kit of Qiagen (Valencia, VA, USA). RNA from each sample (4 mg) was reverse transcribed using the Invitrogen SuperScript III firststrand synthesis system kit. Reverse transcription products were subjected to polymerase chain reaction for 25 cycles. The polymerase chain reaction products were stained with ethidium bromide and analysed on 1.5% agarose gels. Primers utilized were as follows: Axin, top 5 0 -CACAAGCTGCCT TCTGTCCCAGC-3 0 , bottom 5 0 -GAATTATGGTGAACAT GGTGGTGGC-3 0 ; DAB2, top 5 0 -GGAGCATGTAGACCA TGATG-3 0 , bottom 5 0 -AAAGGATTTCCGAAAGGGCT-3 0 ; actin, top 5 0 -AGCTGTGCTATGTTGCTCTAGACTT-3 0 , bottom 5 0 -CACTTCATGATGGAATTGAATGTAG-3 0 .
